On Friday, Beyond Air (NASDAQ:XAIR) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data
Companies Reporting Before The Bell • Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss at $0.56 per share on revenue of $2.30 million. • Apogee Enterprises (NASDAQ:APOG) is expected to report quarterly
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
The global financial markets are currently gripped by a palpable sense of unease, as significant stock swings and heightened volatility define the investment landscape of late 2025. This turbulent period is primarily driven by a complex interplay of geopolitical tensions, evolving interest rate expectations, and lingering concerns over inflated valuations
Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company at the forefront of nitric oxide (NO) therapies, announced on November 5, 2025, a significant financing deal of up to $32 million with Streeterville Capital. This strategic financial infusion, comprising a $12 million promissory note and a $20 million
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
